Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

GRAL vs WGS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GRAL Captures Overall Composite Edge (54.5 HOLD vs 49.5 HOLD), While WGS Leads 5–1 on Growth & Valuation Pillars

GRAL Overall Winner 6-Pillar Tally: GRAL 1 – 5 WGS Matrix Metrics: GRAL 7 – 3 WGS

As of Nov 16, 2026, GRAIL, Inc. (GRAL) captures the overall head-to-head institutional edge over GeneDx Holdings Corp. (WGS) on higher Unified Composite conviction (54.5/100 HOLD vs. 49.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples), while WGS wins 5–1 across the 6-pillar growth and valuation breakdown. GRAL trades at $105.60 (1.1x Forward P/E, -332.0% operating margin) versus WGS at $51.02 (40.6x Forward P/E, -13.7% operating margin).

  • Growth vs. Quality Trade-Off: GRAL earns the overall head-to-head edge with a stronger Unified Composite Score (54.5/100 HOLD vs. WGS 49.5/100 HOLD) and 3.09β · 99% Vol risk profile, whereas WGS leads top-line expansion (+5.4% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: GRAL is currently in a Breakdown options structure phase (RSI 37.7); meanwhile WGS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GRAL vs WGS
GRAL NASDAQ Head-to-Head Winner
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
TTM Revenue $167M
Forward P/E 1.1x
Beta / 30D Vol 3.09β · 99% Vol
Unified Composite Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 37.7 · SMA20: $132.32 · SMA50: $121.37
WGS NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap $1.6B
TTM Revenue $461M
Forward P/E 40.6x
Beta / 30D Vol 1.74β · 111% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 35
RSI-14: 34.8 · SMA20: $62.47 · SMA50: $73.13

6-Pillar Scorecard Institutional Category Breakdown (GRAL 1 – 5 WGS)

Columns: Metric · GRAL · WGS
1. Valuation Multiples GRAL
Forward P/E 1.1x 40.6x
Trailing P/E 1.1x 38.8x
PEG Ratio N/M N/M
EV / Revenue 31.6x 3.7x
2. Growth & Scale WGS
Revenue Growth (YoY) +3.7% +5.4%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $167M $461M
Market Cap $5.2B $1.6B
3. Profitability & Quality WGS
Gross Margin 46.7% 68.8%
Operating Margin -332.0% -13.7%
Net Profit Margin -243.8% -24.1%
Return on Equity (ROE) -17.3% -41.4%
4. Balance Sheet & Cash Flow WGS
Cash Generation (TTM) -$312M -$101M
Cash Flow Margin N/A -22.0%
Net Cash / Leverage $57M Net Debt (0.03x D/E) $119M Net Debt (0.88x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning WGS
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 93.0% (53rd %ile) 102.3% (21st %ile)
Put/Call OI Skew 0.81x (Call-Skewed) 7.82x (Put-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat WGS
OpEx & R&D Intensity N/A 82.5% of Rev ($380M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Diagnostics & Research Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GRAL (7) vs WGS (3)
Institutional Metric GRAL WGS Criterion Row Edge
Market Capitalization
Scale
$5.2B $1.6B Larger Scale GRAL
Trailing P/E Ratio
Valuation
1.1x 38.8x Lower Multiple GRAL
Forward P/E Ratio
Valuation
1.1x 40.6x Lower Multiple GRAL
Revenue Growth (YoY)
Growth
+3.7% +5.4% Higher Growth WGS
Operating Margin (TTM)
Profitability
-332.0% -13.7% Higher Margin WGS
Net Profit Margin
Profitability
-243.8% -24.1% Higher Margin WGS
Return on Equity (ROE)
Capital Efficiency
-17.3% -41.4% Higher ROE GRAL
52-Week Range Position
Momentum
51% ($42–$166) 14% ($32–$171) Stronger Trend GRAL
Beta / 30D Volatility
Risk Regime
3.09β · 99% Vol 1.74β · 111% Vol Lower Realized Risk GRAL
Unified Institutional Score
Composite Signal
54.5 / 100 (HOLD) 49.5 / 100 (HOLD) Higher Composite GRAL
Trailing 12M Revenue (USD)
Operating Scale
$167M $461M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
46.7% 68.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 31.6x EV/Rev N/M PEG · 3.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$312M ($57M Net Debt (0.03x D/E)) -$101M ($119M Net Debt (0.88x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GRAL +9.43 pp
GRAL: -10.36% · WGS: -19.79%
3M Horizon GRAL +85.03 pp
GRAL: +50.96% · WGS: -34.07%
6M Horizon GRAL +51.83 pp
GRAL: +77.03% · WGS: +25.2%
1Y Horizon GRAL +87.78 pp
GRAL: +26.92% · WGS: -60.86%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period GRAL Revenue WGS Revenue GRAL Op. Margin WGS Op. Margin Margin Leader
FY2019 N/A $200M N/A -15.5% WGS
FY2020 N/A $180M N/A -134.9% WGS
FY2021 N/A $210M N/A -210.3% WGS
FY2022 N/A $230M N/A -284.5% WGS
FY2023 $90M $200M -1627.6% -89.2% WGS
FY2024 $130M $310M -1743.0% -7.6% WGS
FY2025 $150M $430M -382.0% -3.1% WGS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GRAL BREAKDOWN
12d in phase · OBV DISTRIBUTION
Current IV 93.0%
IV Percentile 53rd %ile
Put/Call OI Skew 0.81x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact GRAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WGS BREAKDOWN
96d in phase · OBV DISTRIBUTION
Current IV 102.3%
IV Percentile 21st %ile
Put/Call OI Skew 7.82x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GRAL Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $5.2B market capitalization and -332.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
WGS Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $1.6B market capitalization and -13.7% operating margin.
OpEx & R&D Reinvestment 82.5% of Rev ($380M)
90D Engineering Disclosures 0 Published

Investor FAQ GRAL vs WGS Key Questions & Quantitative Answers

As of Nov 16, 2026, GRAIL, Inc. (GRAL) captures the overall head-to-head institutional edge over GeneDx Holdings Corp. (WGS) on higher Unified Composite conviction (54.5/100 HOLD vs. 49.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples), while WGS wins 5–1 across the 6-pillar growth and valuation breakdown. GRAL trades at $105.60 (1.1x Forward P/E, -332.0% operating margin) versus WGS at $51.02 (40.6x Forward P/E, -13.7% operating margin). Growth vs. Quality Trade-Off: GRAL earns the overall head-to-head edge with a stronger Unified Composite Score (54.5/100 HOLD vs. WGS 49.5/100 HOLD) and 3.09β · 99% Vol risk profile, whereas WGS leads top-line expansion (+5.4% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: GRAL is currently in a Breakdown options structure phase (RSI 37.7); meanwhile WGS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

WGS leads the Growth & Scale pillar: GRAL posts +3.7% YoY revenue growth and +0.0% YoY earnings growth on $167M TTM revenue (46.7% gross margin, -332.0% operating margin), compared with WGS at +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), GRAL cumulative revenue shifted +66.7% while WGS shifted +115.0%. In operating R&D and SG&A reinvestment, GRAL deploys N/A (0 90-day corporate R&D disclosures) versus 82.5% of Rev ($380M) (0 disclosures) for WGS.

GRAL screens cheaper on headline valuation multiples. GRAL trades at 1.1x Forward P/E, 1.1x Trailing P/E, N/M PEG, and 31.6x EV/Revenue (unreported FCF margin), whereas WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GRAL (-17.3% ROE) versus WGS (-41.4% ROE) capital efficiency.

In options market volatility and institutional positioning, GRAL carries 93.0% implied volatility (53rd %ile, Balanced (25th–60th %ile)), a 0.81x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.09β · 99% Vol realized risk). By comparison, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.